Traws Pharma (TRAW) Earnings Date, Estimates & Call Transcripts $1.41 +0.03 (+2.17%) Closing price 04:00 PM EasternExtended Trading$1.40 -0.01 (-1.06%) As of 07:14 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisChartCompetitorsEarningsFDA EventsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Traws Pharma Earnings Summary Traws Pharma issued Q2 2025 earnings on August 14, 2025, reporting an EPS of -$0.11, which topped the consensus estimate of -$8.75 by $8.64. Quarterly revenue was reported to be $2.73 million, above analyst estimates of $0.06 million. Traws Pharma currently has a trailing EPS of $88.83 and a P/E Ratio of 0.02Latest Q2 Earnings DateAug. 14EstimatedConsensus EPS (Aug. 14) -$8.75 Actual EPS (Aug. 14) -$0.11 Beat By $8.64 Actual Revenue (Aug. 14) $2.73MQ2 2025 Earnings ResourcesQ2 2025 Earnings ReportConference Call Transcript & Audio Quarterly Report (10-Q) Press Release (8-K)Powered by Get Traws Pharma Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Traws Pharma and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataTRAW Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.TRAW Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Traws Pharma Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251-$0.31-$0.31-$0.31Q2 20251-$0.33-$0.33-$0.33Q3 20251-$0.35-$0.35-$0.35Q4 20251-$0.36-$0.36-$0.36 Traws Pharma Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails8/14/2025Q2 2025-$8.75-$0.11+$8.64-$0.11$0.06M$2.73M5/15/2025Q1 2025-$8.04$2.09+$10.13$2.09$0.06M$0.06M3/31/2025Q4 2024 & Study Update-$7.00$95.66+$102.66$95.66$0.06M$0.06M8/15/2024Q2 2024--$4.87--$4.87-$0.06M5/15/2024Q1 2024-$0.24-$0.24--$0.24$0.06M$0.06M4/1/2024Q4 2023--$0.20--$0.20-$0.06M11/14/2023Q3 2023-$0.26-$0.23+$0.03-$0.23$0.06M$0.06M Traws Pharma Earnings - Frequently Asked Questions When did Traws Pharma announce their last quarterly earnings? Traws Pharma (NASDAQ:TRAW) last announced its quarterly earning data on Thursday, August 14, 2025. Learn more on TRAW's earnings history. Did Traws Pharma beat their earnings estimates last quarter? In the previous quarter, Traws Pharma (NASDAQ:TRAW) reported ($0.11) earnings per share (EPS) to beat the analysts' consensus estimate of ($8.75) by $8.64. Learn more on analysts' earnings estimate vs. TRAW's actual earnings. How can I listen to Traws Pharma's earnings conference call? The conference call for Traws Pharma's latest earnings report can be listened to online. Listen to Conference Call How can I read Traws Pharma's conference call transcript? The conference call transcript for Traws Pharma's latest earnings report can be read online. Read Transcript How much revenue does Traws Pharma generate each year? Traws Pharma (NASDAQ:TRAW) has a recorded annual revenue of $230,000.00. How much profit does Traws Pharma generate each year? Traws Pharma (NASDAQ:TRAW) has a recorded net income of -$166.52 million. TRAW has generated $88.83 earnings per share over the last four quarters. What is Traws Pharma's price-to-earnings ratio? Traws Pharma (NASDAQ:TRAW) has a trailing price-to-earnings ratio of 0.02. More Earnings Resources from MarketBeat Related Companies LVTX Earnings Date RENB Earnings Date RANI Earnings Date AADI Earnings Date ITRM Earnings Date OKUR Earnings Date PLUR Earnings Date MRSN Earnings Date XLO Earnings Date KLTO Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles After Earnings Miss, Walmart Is Still a Top Consumer Staples PlayRoyal Caribbean Earnings Beat Fuels Strong 2025 OutlookDLocal Stock Soars 43% After Earnings Beat and Raised GuidanceGreen Dot's 30% Rally: Turnaround Takes Off on Explosive EarningsElbit Systems Jumps on Record Earnings and a $1.6B ContractBrinker Serves Up Earnings Beat, Sidesteps Cost PressuresWhy BigBear.ai Stock's Dip on Earnings Can Be an Opportunity This page (NASDAQ:TRAW) was last updated on 8/22/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredUS attacks China, September 30?The White House just ordered more than 400 government agencies to prepare for the next phase of America’s econ...Stansberry Research | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Traws Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Traws Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access